Defining organ involvement in sarcoidosis: The ACCESS proposed instrument

Sarcoidosis Vasculitis and Diffuse Lung Disease

Volumn 16, Issue 1, 1999, Pages 75-86

  Judson, Marc A ^a,f   Baughman, Robert P ^b   Teirstein, Alvin S ^c   Terrin, Michael L ^d   Yeager Jr , Henry ^e  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

^d Clinical Trials & Surveys Corp   (United States)

^e GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Extrapulmonary sarcoidosis; Sarcoidosis; Sarcoidosis organ involvement

Indexed keywords

ARTICLE; EYE; HUMAN; HUMAN TISSUE; KIDNEY; LIVER; LUNG; PRIORITY JOURNAL; SARCOIDOSIS; SKIN;

BONE DISEASES; EYE DISEASES; GASTROINTESTINAL DISEASES; HUMANS; REPRODUCIBILITY OF RESULTS; SARCOIDOSIS; SARCOIDOSIS, PULMONARY; SEVERITY OF ILLNESS INDEX; SKIN DISEASES;

EID: 0032933171     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (115)

1. Scadding JG: Prognosis of intrathoracic sarcoidosis in England. Br Med J 1961; 2: 1165-1172.
2. Watters LC, King TE, Schwartz MI et al: A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 1986; 133: 97-103.
3. Siltzbach LE: Sarcoidosis: Clinical features and management. Med Clin N Amer 1967; 51: 483-502.
4. Siltzbach LE, James DG, Neville E et al: Course and prognosis of sarcoidosis around the world. Am J Med 1974; 57: 847-852.
5. Sharma O: Pulmonary sarcoidosis: Radiographic features. In Sarcoidosis and Other Granulomatous Disorders, ed. by DG James. New York, Marcel Dekker, 1994, pp. 213-245.
6. Teirstein AS, Siltzbach LE: Sarcoidosis of the upper lung fields simulating pulmonary tuberculosis. Chest 1973; 64: 303-308.
7. Epler GR, MCLoud TC, Gaensler EA et al: Normal chest roentgenograms in chronic diffuse infiltrative lung disease. N Eng J Med 1978; 298: 934-939.
8. Winterbauer RH, Lammert J, Selland M, Wu R, Corley D, Springmeyr SC: Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis. Chest 1993; 104: 352-361.
9. Drent M, van Nierop MA, Gerritsen FA, Wouters EF, Mulder PG: A computer program using BALF-analysis results as a diagnostic tool in interstitial lung disease. Am J Respir Crit Care Med 1996; 153: 736-741.
10. Badr AI, Sharma O: Pulmonary function. In Sarcoidosis and Other Granulomatous Diseases. ed. by DG James, New York, Marcel Dekker, 1994, pp. 247-266.
11. James DG, Angi MR: Ocular sarcoidosis. In Sarcoidosis and Other Granulomatous Disorders, ed. by DG James. New York, Marcel Dekker, 1994, pp. 275-284.
12. Angi MR, Forattini F, Cipriani A, Capelli P, Semenzato G: Ophthalmic changes in sarcoidosis: A prospective study of 308 patients. In Proceedings of the XI World Congress on Sarcoidosis and Other Granulomatous Disorders, ed. by C Grassi, G Rizzato, E Pozzi. London, Elsevier, 1988, pp. 493-497.
13. Pietinalho A, Ohmichi M, Hiraga Y, Löfroos AB, Selroos O: The mode of presentation of sarcoidosis in Finland and Hokkaido, Japan. A comparative analysis of 571 Finnish and 686 Japanese patients. Sarcoidosis Vasc Diff Lung Dis 1996; 13: 159-166.
14. Rizzato G: An iceberg from Hokkaido and Scandinavia. Sarcoidosis Vase Diffuse Lung Dis 1996; 13: 117-119.
15. Khan F, Wessley Z, Chazin SR, Seriff NS: Conjuctival biopsy in sarcoidosis. Ann Opthalmol 1977; 9: 671-676.
16. Nichols CW, Eagle RC, Yanoff M, Menocal NG: Conjuctival biopsy as an aid in the evaluation of the patient with suspected sarcoidosis. Ophthalmology 1980; 87: 287-291.
17. Karma A: Diagnosing sarcoidosis by transconjunctival biopsy of the lacrimal gland. Am J Ophthalmol 1984; 98: 640-641.
18. Katz S: Clinical presentation and natural history of sarcoidosis. In Sarcoidosis and Other Granulomatous Diseases of the Lung, ed. by BL Fanburg. New York, Marcel Dekker, 1983, pp. 3-36.
19. James DG: Dermatological aspects of sarcoidosis. Quart J Med 1959; 28: 109-127.
20. James DG, Epstein WL: Cutaneous sarcoidosis. In Sarcoidosis and Other Granulomatous Disorders, ed. by DJ James. New York, Marcel Dekker, 1994, pp. 311-322.
21. Sharma OP: Sarcoidosis of the skin. In Dermatology in General Medicine, 4th, ed. TB Fitzpatrick et al. (Eds) New York, McGraw-Hill, 1993, pp. 2221-2228.
22. Löfgren S: Primary pulmonary sarcoidosis. Acta Med Scand 1953; 145: 424-443.
23. Nakata K, Iwata K, Kojima K, Kanai K: Computed tomography of liver in sarcoidosis. J Comp Assist Tomogr 1989; 13: 707-708.
24. Warshauer DM, Dumbleton SA, Molina PL, Yankaskas BC, Parker LA, Woosley JT: Abdominal CT findings in sarcoidosis: radiologic and clinical correlation. Radiology 1994; 192: 93-98.
25. Warshauer DM, Molina PL, Hamman SM et al: Nodular sarcoidosis of the liver and spleen: analysis of 32 cases. Radiology 1995; 195: 757-762.
26. Maddrey WC, Johns CJ, Boitnott JK, Iber FL: Sarcoidosis and chronic hepatic disease: A clinical and pathologic study of 20 patients. Medicine 1970; 49: 375-395.
27. Pereira-Lima J, Schaffner F: Chronic cholestasis in hepatic sarcoidosis with clinical features resembling primary biliary cirrhosis. Am J Med 1987; 83: 144-148.
28. Sherlock S: The liver in sarcoidosis. In Sarcoidosis and Other Granulomatous Disorders, ed. by DG James. New York, Marcel Dekker, 1994, pp. 375-386.
29. James DG, Nevill E, Siltzbach LE et al: A worldwide review of sarcoidosis. Ann NY Acad Sci 1976; 278: 321-334.
30. Goldstein RA, Israel HL, Becker KL et al: The infrequency of hypercalcemia in sarcoidosis. Am J Med 1971; 51: 21-30.
31. Sharma OP: Vitamin D, Calcium, and Sarcoidosis. Chest 1996; 109: 535-539.
32. Basile JN, Liel Y, Shary J, Bell NH: Increased calcium intake does not suppress circulating 1,25-dihydroxyvitamin D in normocalcemic patients with sarcoidosis. J Clin Invest 1993; 91: 1396-1398.
33. Adams J: Hypercalcemia and hypercalciuria. Semin Respir Med 1992; 13: 402-410.
34. Scadding JG: The kidney and calcium metabolism. In sarcoidosis, ed. by JG Scadding and DN Mitchell. London, Chapnan and Hall Medical, 1985, pp. 390-413.
35. Lebacq E, Verhaegen H, Desmet V: Renal involvement in sarcoidosis. Postgrad Med 1970; 46: 526-529.
36. Chapelon C, Ziza JM, Piette JC et al: Neurosarcoidosis: Signs, course and treatment in 35 confirmed cases. Medicine 1990; 69: 261-276.
37. Oksanen V: Neurosarcoidosis: Clinical presentations and course in 50 patients. Acta Neurol Scand 1986; 73: 283-290.
38. Delaney P: Neurologic manifestations in sarcoidosis - Review of the literature, with a report of 23 cases. Ann Intern Med 1977; 87: 336-345.
39. Stern BJ, Krumholz A, Johns C, Scott P, Nissim J: Sarcoidosis and its neurological manifestations. Arch Neurol 1985; 42: 909-915.
40. Lucia SP, Aggeler PM: Sarcoidosis (Boeck), lymphogranulomatosis benigna (Schaumann); observations on the bone marrow obtained by sternal puncture. Acta Med Scand 1940; 54: 351-365.
41. Urich H: Neurological manifestations of sarcoidosis. Practitioner 1969; 202: 632-636.
42. Lewis R, Wilson J, Smith FW: Diabetes insipidus secondary to intracranial sarcoidosis confirmed by low-field magnetic resonance imaging. Magn Reson Med 1987; 5: 466-470.
43. Winnacker JL, Becker KL, Katz S: Endocrine aspects of sarcoidosis. N Engl J Med 1968; 278: 427-434, 483-492.
44. Lexa F, Grossman RI: MR of sarcoidosis in the head and spine: Spectrum of manifestations and radiographic response to steroid therapy. AJNR 1994; 15: 973-982.
45. Matthews WB: Neurologic manifestations of sarcoidosis. In: Diseases of the nervous system II. Asbury, Mc Khann, McDonald. Saunders, Philadelphia, pp. 1563-1569.
46. Gaines JD, Eckman PB, Remington Arch Intern Med JS: Low CSF glucose in sarcoidosis involving the central nervous system. Arch Intern Med 1970; 125-: 333-336.
47. Silverstein A, Siltzbach LE: Muscle involvement in sarcoidosis. Arch Neurol 1969; 21: 235-241.
48. Hennedouche T, Grateau G, Noel LH et al: Renal granulomatous sarcoidosis. Report of six cases. Nephrol Dial Transpl 1990; 5: 18-24.
49. Silverman KJ, Hutchins GM, Bulkley BH: Cardiac sarcoidosis: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978; 58: 1204-1211.
50. Johns CJ, Pay H, Kasper EK, Baughman K: Myocardial sarcoidosis: Course and management. Sarcoidosis 1992; 9 (suppl 1): 231-236.
51. Fleming H: Sarcoid heart disease. Thorax 1980; 35: 641-643.
52. Matsiu Y: Clinicopathological study of fatal myocardial sarcoidosis. Ann NY Acad Sci 1976; 278: 455-469.
53. Winters SL, Cohen M, Greenberg S et al: Sustained ventricular tachycardia associated with sarcoidosis: Assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol 1991; 18: 1-7.
54. 67 in myocardial sarcoidosis. Clin Nucl Med 1990; 15: 408-411.
55. 67 citrate after prednisone in a case of biopsy-proven cardiac sarcoidosis. Sarcoidosis 1992; 9: (Suppl. 1): 260.
56. Hirose Y, Ishida Y, Hayashida K et al: Myocardial involvement in patients with sarcoidosis. An analysis of 75 patients. Clin Nucl Med 1994; 19: 522-526.
57. Okayama K, Kurata C, Tawarahara K, Wakabayashi Y, Chida K, Sato A: Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest 1995; 107: 330-334.
58. Yamamoto N, Gotoh K, Yagi E et al: Thallium-201 myocardial SPECT findings at rest in sarcoidosis. Ann Nucl Med 1993; 7: 97-103.
59. Myock RL, Bertrand P, Morrison CE: Manifestations of sarcoidosis. Am J Med 1963; 35: 67-89.
60. James DG, Siltzbach LE, Sharma OP, Carstairs LS: A tale of two cities: A comparison of sarcoidosis in London and New York. Arch Intern Med 1969; 123: 187-191.
61. Keller AZ: Anatomic sites, age attributes, and rates of sarcoidosis in U.S. veterans. Am Rev Respir Dis 1973; 107: 615-620.
62. Young RC, Jr., Titus-Dillon PY, Schneider ML, Shelton TG, Hackney RL, Jr., Harden KA: Sarcoidosis in Washington, D.C. Clinical observations in 105 black patients. Arch Intern Med 1970; 125: 102-105.
63. Daly PA, O'Brian DS, Robinson I, Guckian M, Prichard JS: Hodgkin's disease with a granulomatous pulmonary presentation mimicking sarcoidosis. Thorax 1988; 43:407-409.
64. Fazzi P, Solfanelli S, Morelli G et al: Sarcoidosis: single bulky mesenteric lymph node mimicking a lymphoma. Sarcoidosis 1995; 12: 75-77.
65. Sharma OP, Meyer PR, Akii B, Nademanee A, Owens CM: Sarcoidosis and lymphoma: an unusual association. Sarcoidosis 1987; 4: 58-63.
66. Brinker H, Pederson NT: Immunologic marker patterns in granulomatous lymph node lesions. Histopathology 1989; 15: 495-503.
67. Brinker H: Granulomatous lesions of unknown significance in biopsies of lymph nodes and other tissue: the GLUS syndrome. Sarcoidosis 1990; 7: 28-30.
68. Freidland JS, Weatherall DJ, Ledingham JGG: A chronic granulomatous syndrome of unknown origin. Medicine 1990; 69: 325-331.
69. Nakata K, Iwata K, Kojima K, Kanai K: Computed tomography of liver sarcoidosis. J Comp Assist Tom 1989; 13: 707-708.
70. Kessler A, Mitchell DG, Israel HL, Goldberg BB: Hepatic and splenic sarcoidosis: ultrasound and MR imaging. Abdom Imaging 1993; 18: 159-163.
71. Flickinger FW, Pfeifer EA: Hepatic sarcoidosis: MR findings. AJR 1991; 156: 1324-1325.
72. Browne PM, Sharma OP, Salkin D: Bone marrow sarcoidosis. JAMA 1978; 240: 2654-2655.
73. Lower EE, Smith JT, Martelo OJ, Baughman RP: The anemia of sarcoidosis. Sarcoidosis 1988; 5: 51-55.
74. Means RTJ: Pathogenesis of the anemia of chronic disease: a cytokine-mediated anemia. Stem Cells 1995; 13: 32-37.
75. Hoffbrand BI: Occurrence and significance of lymphopenia in sarcoidosis. Am Rev Respir Dis 1968; 98: 107-110.
76. Kennedy D, Yamakido M: Hematologic manifestations of sarcoidosis. Semin Resp Med 1992; 13: 455-458.
77. Baughman RP, Hurtubise PE: Systemic immune response of patients with active pulmonary sarcoidosis. Clin Exp Immunol 1985; 61: 535-541.
78. Hunninghake GW, Crystal RG: Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis: site of increased antibody production and role of T-lymphocyte. J Clin Invest 1981; 67: 86-96.
79. Knodel AR, Beekman JF: Severe thrombocytopenia and sarcoidosis. JAMA 1980; 243: 258-259.
80. Lawrence HJ, Greenberg BR: Autoimmune thrombocytopenia in sarcoidosis. Am J Med 1985; 79: 761-764.
81. Selroos O, Koivunen E: Usefulness of fine needle aspiration biopsy of spleen in diagnosis of sarcoidosis. Chest 1983; 83: 193-195.
82. Kataria YP, Whitcomb ME: Splenomegaly in sarcoidosis. Arch Intern Med 1980; 140: 35-37.
83. Salazar A, Maña J, Corbella X, Albareda JM, Pujol R: Splenomegaly in sarcoidosis: a report of 16 cases. Sarcoidosis 1995; 12: 131-134.
84. Rohatgi PK: Osseous sarcoidosis. Semin Resp Med 1992; 13: 468-488.
85. Neville E, Walker AN, James DG: Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med 1983; 208: 525-533.
86. James DG, Neville E, Carstairs LS: Bone and joint involvement. Semin Arthritis Rheum 1976; 6: 53-81.
87. Rahbar M, Sharma OP: Hypertrophic osteoarthropathy in sarcoidosis. Sarcoidosis 1990; 7: 125-127.
88. Hashmi S, Kaplan D: Asymmetric clubbing as a manifestation of sarcoid bone disease. Am J Med 1992; 93: 471.
89. Rizzato G, Montemurro L: The locomotor system. In Sarcoidosis and Other Granulomatous Disorders, ed. by DG James New York, Marcel Dekker 1994, p 349-373.
90. Bower JS, Belen JE, Weg JG, Dantzker DR: Manifestations and treatment of laryngeal sarcoidosis. Am Rev Respir Dis 1980; 122: 325-332.
91. Krespi YP, Kuriloff DB, Aner M: Sarcoidosis of the sinonasal tract: a new staging system. Otolaryngol Head Neck Surg 1995; 112: 221-227.
92. Wilson R, Lund V, Sweatman M, Mackay IS, Mitchell DN: Upper respiratory tract involvement in sarcoidosis and its management. Eur Respir J 1988; 1: 269-272.
93. Livas I, Essayan DM: A 54-year-old woman with rhinitis and a right ethmoid sinus mass [clinical conference]. Ann Allergy Asthma Immunol 1996; 76: 405-410.
94. Milgrim LM, Cohen AF: Nonpulmonary sinonasal sarcoidosis with intracranial invasion. Otolaryngol Head Neck Surg 1996; 114: 162-165.
95. James DG: Alimentary tract. In Sarcoidosis and Other Granulomatous Disorders, ed. by DG James. New York, Marcel Dekker, 1994, pp. 421-428.
96. Israel HL, Albertini KH, Park CH, Patrick H: Whole-body gallium 67 scans. Role in diagnosis of sarcoidosis. Am Rev Respir Dis 1991; 144: 1182-1186.
97. Sulavik SB, Spencer RP, Palestro CJ, Swyer AJ, Teirstein AS, Goldsmith SJ: Specificity and sensitivity of distinctive chest radiographic and/or 67Ga images in the non-invasive diagnosis of sarcoidosis. Chest 1993; 103: 403-409.
98. Johnson DL, Yamakido M, Sharma OP: Musculoskeletal involvement in sarcoidosis. Semin Resp Med 1992; 13: 415-419.
99. Jamal MM, Cilursu AH, Hoffman EL: Sarcoidosis presenting as acute myositis. Report and review of literature. J Rheumatol 1988; 15: 1868-1878.
100. Ost D, Yeldandi A, Cugell D: Acute sarcoid myositis with respiratory muscle involvement Case report and review of the literature. Chest 1995; 107; 879-882.
101. Ando DG, Lynch JPI, Fantone JC: Sarcoid myopathy with elevated creatinine phosphokinase. Am Rev Respir Dis 1985; 131: 293-300.
102. DeRemee RA, Rohrbach MS: Serum angiotensin-converting enzyme activity in evaluating the clinical course of sarcoidosis. Ann Intern Med 1980; 92: 361-365.
103. Rohatgi PK, Ryan JW, Lindeman P: Value of serial measurement of serum angiotensin converting enzyme in the management of sarcoidosis. Am J Med 1981; 70: 44-50.
104. Simon MR, Desai SG, Lee KK et al: Method for the derivation of clinical and laboratory indices in relation to disease activity and outcome for sarcoidosis. Chest 1986; 89: 138-140.
105. Thomas PD, Hunninghake GW: Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis 1987; 135: 747-760.
106. Keogh BA, Hunninghake GW, Line BR, Crystal RG: The alveolitis of pulmonary sarcoidosis. Am Rev Respir Dis 1983; 128: 256-265.
107. Klech H, Kohn H. Kummer F, Mostbeck A: Assessment of activity in sarcoidosis. Chest 1982; 82: 732-738.
108. Dawson WB, Muller NL: High-resolution computed tomography in pulmonary sarcoidosis. Semin Ultrasound, CT, MR 1990; 11: 423-429.
109. Luisetti M, Bulgheroni A, Bacchella L, Pasturenzi L, Aprile C: Elevated serum procollagen III aminopeptide levels in sarcoidosis. Chest 1990; 98: 1414-1420.
110. Pohl WR, Thompson AB, Köhn H et al: Serum procollagen III peptide levels in subjects with sarcoidosis. A five year study. Am J Resp Dis 1992; 145: 412-417.
111. Costabel U: Biochemistry. In Sarcoidosis and Other Granulomatous Disorders, ed by DG James. New York, Marcel Dekker, 1994, pp. 429-463.
112. Selroos O, Sellergen TL: Corticosteroid therapy of pulmonary sarcoidosis. Scand J Resp Dis 1979; 60: 215-221.
113. Zaki MH, Lyons HA, Leilop L, Huang CT: Corticosteroid therapy in sarcoidosis. NY State J Med 1987; 87: 496-499.
114. Harkleroad LE, Young RL, Savage PJ, Jenkins DW, Lordon RE: Pulmonary sarcoidosis. Longterm follow-up of the effects of steroid therapy. Chest 1982; 82: 84-87.
115. Limper AH, Colby TV, Sanders MS, Asakura S, Roche PC. DeRemee RA: Immunohistochemical localization of transforming growth factor-beta, in the nonnecrotizing granulomas of pulmonary sarcoidosis. Am J Respir Crit Care Med 1994; 149: 197-204.